Topic: Food and Drug Administration

NEW YORK (Reuters) - The U.S. Food and Drug Administration declined to approve an experimental epilepsy drug from GlaxoSmithKline and Valeant Pharmaceuticals International, the companies said on Wednesday, marking another delay for the anti-seizure medicine.The drugmakers received a so-called complete response letter ...

The FDA Law Blog reported yesterday on an Oct. 7 response by the Food & Drug Administration (FDA) to a state senator in New Jersey who had written the agency seeking its opinion on a bill that would " The letter pointedly ...

Phenobarbital (INN ) or phenobarbitone (former BAN ) is a barbiturate , first marketed as Luminal by Friedr. For this purpose phenobarbital has a lower dose range - around 30?120 mg/day; however this practice is uncommon in developed countries.The first barbiturate drug, ...

Potassium bromide (K Br ) is a 2[CuBr4](aq ) A traditional method for the manufacture of KBr is the reaction of potassium carbonate with a bromide of iron , Fe3Br8, made by treating scrap iron under water with excess bromine : 8 ...

Nitrazepam is most often used to treat short-term sleeping problems (insomnia ), namely difficulty falling asleep, frequent awakening, early awakenings or a combination of each. However, as with other epilepsies treated with benzodiazepines, long term therapy becomes ineffective with prolonged therapy and ...

QCOR) today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. ...

In drug stores and medical clinics, pharmacists dispense drug medications following the prescribing doctor's instructions. Florida has state regulations that govern how and when pharmacists can substitute a generic drug. The FDA has produced an Orange Book listing generic drugs that can ...

About 6 million women become pregnant in the US every year. The average mom-to-be uses three to five prescription drugs during her pregnancy. While the potential impact of prescription medication upon an unborn child is always a concern, many expecting women must ...

In the second week in May, the Peripheral and Central Nervous System Drugs Advisory Committee to the FDA held a panel meeting to discuss approval for using Questcor's (QCOR) Acthar in the treatment of infantile spasms. The key points of this meeting ...

In the second week in May, the Peripheral and Central Nervous System Drugs Advisory Committee to the FDA held a panel meeting to discuss approval for using Questcor's (QCOR) Acthar in the treatment of infantile spasms. The FDA is currently reviewing information ...